CMG Pharmaceutical Co. Ltd (058820) — Capital Reinvestment Ratio
CMG Pharmaceutical Co. Ltd (058820) has a Capital Reinvestment Ratio of 109.44x as of December 2024, meaning it reinvests 109% of its operating cash flow (₩290.09 Million) in capital expenditures (₩31.75 Billion). Check CMG Pharmaceutical Co. Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
CMG Pharmaceutical Co. Ltd Capital Reinvestment Ratio (2014–2024)
This chart tracks CMG Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of CMG Pharmaceutical Co. Ltd.
Annual Capital Reinvestment Ratio for CMG Pharmaceutical Co. Ltd (2014–2024)
Year-by-year Capital Reinvestment Ratio for CMG Pharmaceutical Co. Ltd from 2014 to 2024. See how much free cash does CMG Pharmaceutical Co. Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 109.44x | ₩290.09 Million | ₩31.75 Billion | ▲ +2706.1% |
| 2023 | 3.90x | ₩3.91 Billion | ₩15.25 Billion | ▲ +86.8% |
| 2022 | 2.09x | ₩4.94 Billion | ₩10.31 Billion | ▲ +197.4% |
| 2021 | 0.70x | ₩5.63 Billion | ₩3.95 Billion | ▼ -78.6% |
| 2020 | 3.28x | ₩2.94 Billion | ₩9.65 Billion | ▲ +13.2% |
| 2019 | 2.90x | ₩2.82 Billion | ₩8.18 Billion | ▲ +0.9% |
| 2018 | 2.87x | ₩886.78 Million | ₩2.55 Billion | ▲ +635.3% |
| 2017 | 0.39x | ₩1.95 Billion | ₩760.59 Million | ▲ +12.8% |
| 2016 | 0.35x | ₩2.31 Billion | ₩799.00 Million | ▼ -77.0% |
| 2015 | 1.51x | ₩2.41 Billion | ₩3.64 Billion | ▼ -88.4% |
| 2014 | 13.00x | ₩724.89 Million | ₩9.42 Billion | — |